Back | Next |
home / stock / ikt / ikt message board
Subject | By | Source | When |
---|---|---|---|
bears and bulls | conix | investorshub | 04/10/2023 5:42:14 PM |
$IKT When is this gonna take off? | jedijazz | investorshub | 04/10/2023 9:55:48 AM |
$IKT Price gaining last trade up | conix | investorshub | 04/10/2023 9:35:05 AM |
$IKT oh yeah news for the day | heyitsmeagain | investorshub | 04/10/2023 8:09:24 AM |
MomentumIts now up | conix | investorshub | 04/10/2023 7:17:19 AM |
$IKT Price now last up | conix | investorshub | 04/10/2023 4:11:18 AM |
$IKT short squeeze all day | ProfitScout | investorshub | 04/10/2023 3:03:23 AM |
best news of the day | conix | investorshub | 04/09/2023 6:41:27 PM |
$IKT where is the squeeze? | conix | investorshub | 04/09/2023 5:33:41 PM |
$IKT short squeeze all day | conix | investorshub | 04/09/2023 4:52:13 PM |
MomentumIts gaining up | conix | investorshub | 04/09/2023 12:20:12 PM |
$IKT Found an interesting article | conix | investorshub | 04/09/2023 4:23:38 AM |
Looks pretty positive | conix | investorshub | 04/09/2023 3:31:34 AM |
Price trading | heyitsmeagain | investorshub | 04/09/2023 3:27:31 AM |
Have a look at this | conix | investorshub | 04/08/2023 5:09:26 AM |
good read | heyitsmeagain | investorshub | 04/07/2023 11:32:30 PM |
Time for a bounce? | conix | investorshub | 04/07/2023 12:52:55 PM |
are we finally gonna see some action | estreet7883 | investorshub | 04/07/2023 4:00:13 AM |
$IKT Price trading last up | ProfitScout | investorshub | 04/07/2023 2:05:36 AM |
Do we have a winner?Turn around time? | CarlCarlMcB | investorshub | 04/07/2023 2:05:01 AM |
News, Short Squeeze, Breakout and More Instantly...
Inhibikase Therapeutics Inc. Company Name:
IKT Stock Symbol:
NASDAQ Market:
Inhibikase Therapeutics Inc. Website:
BOSTON and ATLANTA, June 17, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinso...
- Company positioning multiple assets for late-stage development across its therapeutic pipeline – BOSTON and ATLANTA, June 05, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kin...
BOSTON and ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson...